LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 15 of 15: Calculated dose-response metrics. - Dataset (ID:20252)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | GR_AOC |
|---|---|---|
| MDA-MB-231 | PI103 | 0.5673 |
| MDA-MB-231 | PIK-93 | 0.1295 |
| MDA-MB-231 | PLX-4720 | 0.0784 |
| MDA-MB-231 | QL-X-138 | 0.3736 |
| MDA-MB-231 | QL-XII-47 | 0.7423 |
| MDA-MB-231 | R406 | 0.2111 |
| MDA-MB-231 | Radicicol | 0.6714 |
| MDA-MB-231 | Sirolimus | 0.2037 |
| MDA-MB-231 | Ruxolitinib | 0.0816 |
| MDA-MB-231 | Saracatinib | 0.4267 |
| MDA-MB-231 | SB590885 | 0.2277 |
| MDA-MB-231 | Selumetinib | 0.4845 |
| MDA-MB-231 | Sigma A6730 | 0.1431 |
| MDA-MB-231 | Sorafenib | 0.0672 |
| MDA-MB-231 | SU11274 | 0.1224 |
| MDA-MB-231 | Fedratinib | 0.4087 |
| MDA-MB-231 | TGX221 | 0.1834 |
| MDA-MB-231 | Torin1 | 0.7847 |
| MDA-MB-231 | Torin2 | 0.9666 |
| MDA-MB-231 | Tozasertib | 0.9239 |
| MDA-MB-231 | Trametinib | 0.8871 |
| MDA-MB-231 | TWS119 | 0.2400 |
| MDA-MB-231 | Vemurafenib | 0.1272 |
| MDA-MB-231 | WH-4-025 | 0.7824 |
| MDA-MB-231 | Withaferin A | 0.6373 |